Company intelligence / Profile preview

Sciety Venture Partners

Stockholm, Sweden

Ownership: Private
Development stage: Other

Overview

Sciety is the leading life science venture capital firm in the Nordics, specializing in early to growth-stage investments across biotech, medtech, and digital health. They structure syndicate investments for both private and institutional investors, supporting companies from late preclinical to Phase II (biotech/pharma) and late development to commercial traction (medtech/digital health), with a strong track record of exits.

Modalities: Small moleculeBiologicMonoclonal antibodyAntibodyRecombinant proteinProteinOligonucleotideDeviceSoftware
Industry: Investors

Partnerships

Co-investments with leading Nordic and European VC firmsPortfolio collaborations with pharma and medtech investors

Beyond the preview

Go deeper on Sciety Venture Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sciety Venture Partners.

Explore the full profile